In IDH1MUT glioma, we observed strikingly higher expression levels of GLUD1/2 than in IDH1WT glioma, whereas BCAT1/2 expression levels were much lower in IDH1MUT gliomas than in IDH1WT glioma (Figure 3), as has been reported previously [29]. This evidence concerns the gene GLUD1 and central nervous system cancer.